Cardiovascular disease and hypertension risk in living kidney donors: An analysis of health administrative data in Ontario, Canada

Transplantation

Volumn 86, Issue 3, 2008, Pages 399-406

  Garg, Amit X ^a,b,j   Prasad, G V Ramesh ^c   Thiessen Philbrook, Heather R ^a   Ping, Li ^b   Melo, Magda ^b   Gibney, Eric M ^d   Knoll, Greg ^e   Karpinski, Martin ^f   Parikh, Chirag R ^g   Gill, John ^h   Storsley, Leroy ^f   Vlasschaert, Meghan ^a   Mamdani, Muhammad ^b,i  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ ST MICHAEL'S HOSPITAL   (Canada)

^j LONDON HEALTH SCIENCES CENTRE   (Canada)

more..

Author keywords

Cardiovascular disease; Cohort study; Hypertension; Living kidney donation

Indexed keywords

ADULT; AGED; ANGIOPLASTY; ARTICLE; BYPASS SURGERY; CANADA; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE MANAGEMENT; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY DONOR; LIVING DONOR; MALE; PRIORITY JOURNAL; STROKE; KIDNEY TRANSPLANTATION; MEDICAL RECORD; MIDDLE AGED; MORTALITY; NEPHRECTOMY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; NEPHRECTOMY; ONTARIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 52049108550     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31817ba9e3     Document Type: Article

References (46)

1. Ommen ES, Winston JA, Murphy B. Medical risks in living kidney donors: Absence of proof is not proofof absence.Clin J Am Soc Nephrol 2006; 1: 885.
2. Vastag B. Living-donor transplants reexamined: Experts cite growing concerns about safety of donors. JAMA 2003; 290: 181.
3. Boudville N, Prasad GV, Knoll G, et al. Meta-analysis: Risk for hypertension in living kidney donors. Ann Intern Med 2006; 145: 185.
4. Garg AX, Muirhead N, Knoll G, et al. Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression. Kidney Int 2006; 70: 1801.
5. Fehrman-Ekholm I, Elinder C-G, Stenbeck M, et al. Kidney donors live longer. Transplantation 1997; 64: 976.
6. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903.
7. Watnick TJ, Jenkins RR, RackoffP, et al. Microalbuminuria and hypertension in long-term renal donors. Transplantation 1988; 45: 59.
8. D'Almeida P, Keitel E, Bittar A, et al. Long-term evaluation of kidney donors. Transplant Proc 1996; 28: 93.
9. Miller IJ, Suthanthiran M, Riggio RR. Impact of renal donation. Long-term clinical and biochemical follow-up of living donors in a single center. Am J Med 1985; 79: 201.
10. Najarian JS, Chavers BM, McHugh LE, et al. 20 years or more of follow-up of living kidney donors. Lancet 1992; 340: 807.
11. Sobh M, Nabeeh A, el Din AS, et al. Long-term follow-up of the remaining kidney in living related kidney donors. Int Urol Nephrol 1989; 21: 547.
12. Williams SL, Oler J, Jorkasky DK. Long-term renal function in kidney donors: A comparison of donors and their siblings. Ann Intern Med 1986; 105: 1.
13. Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 2006; 17: 2034.
14. Ibrahim HN, Rogers T, Tello A, et al. The performance of three serum creatinine-based formulas in estimating GFR in former kidney donors. Am J Transplant 2006; 6: 1479.
15. Hida M, Iida T, Shimbo T. Renal function after nephrectomy in renal donors. Tokai J Exp Clin Med 1982; 7: 511.
16. Tsai MY, Aras O, Sozen H, et al. Plasma homocysteine levels in living kidney donors before and after uninephrectomy. J Lab Clin Med 2004; 143: 340.
17. Undurraga A, Roessler E, Arcos O, et al. Long-term follow-up of renal donors. Transplant Proc 1998; 30: 2283.
18. Costanza MC. Matching. Prev Med 1995; 24: 425.
19. Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 289: 1652.
20. Alter DA, Naylor CD, AustinP,etal. Effectsofsocioeconomic status on access to invasive cardiac procedures andon mortality after acute myocardial infarction. N Engl J Med 1999; 341: 1359.
21. Juurlink DN, Mamdani MM, Lee DS et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004; 351: 543.
22. Mamdani M, Juurlink DN, Lee DS, et al. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: A population-based cohort study. Lancet 2004; 363: 1751.
23. Bergstralh EJ, Kosanke JL. Technical Report Series No. 55, Computerized matching of cases to controls. Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, 1995.
24. Tu K, Campbell NRC, Chen Z-L, et al. Validation of administrative databases in identifying patients with hypertension. Open Med 2007; 1: E3.
25. Mamdani M, Sykora K, Li P, et al. Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 2005; 330: 960.
26. Pocock SJ. Clinical trials: A practical approach. Chichester, England, Wiley, 1983.
27. Liang KY, Zeger SL. Longitudinal data analysis using general linear models. Biometrika 1986; 73: 13.
28. Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics 1983; 39: 499.
29. Stein JH. Regulation of the renal circulation. Kidney Int 1990; 38: 571.
30. Hostetter TH, Olson JL, Rennke HG, et al. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. J Am Soc Nephrol 2001; 12: 1315.
31. Yang RC, Thiessen-Philbrook H, Klarenbach S, et al. Insurability of living organ donors: A systematic review. Am J Transplant 2007; 7: 1542.
32. Housawi AA, Young A, Boudville N, et al. Transplant professionals vary in the long-term medical risks they communicate to potential living kidney donors: An international survey. Nephrol Dial Transplant 2007.
33. Young A, Karpinski M, Treleaven D, et al. Tolerance for health risks to the living donor differs between potential donors, recipients and transplant professionals. Kidney Int 2008; 73: 1159.
34. Spital A. Public attitudes toward kidney donation by friends and altruistic strangers in the United States. Transplantation 2001; 71: 1061.
35. Cohen J. Statistical power analysis for the behavioural sciences. Hillsdale, New Jersey, Academic Press, 1988.
36. Jha P, Deboer D, Sykora K, et al. Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: A population-based comparison. J Am Coll Cardiol 1996; 27: 1335.
37. Austin PC, Daly PA, Tu JV. A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J 2002; 144: 290.
38. Juurlink DN, Preya C, Croxford R, et al. Canadian Institute for Health Information Discharge Abstract Database: A validation study. Institute for Clinical Evaluative Sciences, Toronto, 2006.
39. Liu L, Reeder B, Shuaib A, et al. Validity of stroke diagnosis on hospital discharge records in Saskatchewan, Canada: implications for stroke surveillance. Cerebrovasc Dis 1999; 9: 224.
40. Richards J, Brown A, Homan C.The data quality study of the Canadian discharge abstract database. Proceedings of Statistics Canada Symposium 2001; Achieving Data Quality in a Statistical Agency, 2001.
41. Canadian Institute for Health Information. Discharge abstract database data quality re-abstraction study: Combined findings for 1999/ 2000 and 2000/2001. Canadian Institute for Health Information, Ottawa 2002.
42. Williams J, Young W. A summary of studies on the quality of health care administrative databases in Canada. In: Goel V, Williams JI, Anderson GM, et al, eds. Patterns of Health Care in Ontario. The ICES Practice Atlas. Ottawa, Canadian Medical Association, 1996.
43. Raina P, Torrance-Rynard V, Wong M, et al. Agreement between self-reported and routinely collected health-care utilization data among seniors. Health Serv Res 2002; 37: 751.
44. Potter BK, Manuel D, Speechley KN, et al. Is there value in using physician billing claims along with other administrative health care data to document the burden of adolescent injury? An exploratory investigation with comparison to self-reports in Ontario, Canada. BMC Health Serv Res 2005; 5: 15.
45. Hemmelgarn BR, McAllister FA, Myers MG, et al. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1. Blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2005; 21: 645.
46. Hux JE, Ivis F, Flintoft V, et al. Diabetes in Ontario: Determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002; 25: 512.